Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

NCT: NCT04829994 · ACTIVE_NOT_RECRUITING

NCT IDNCT04829994
StatusACTIVE_NOT_RECRUITING
Start Date2021-07-07
Completion2035-09-30

Brief Summary

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retropubic mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

Frequently Asked Questions

What is Post-Market Clinical Follow-Up onTVT EXACT® Continence System?

Post-Market Clinical Follow-Up onTVT EXACT® Continence System is a clinical trial registered under NCT04829994. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04829994?

The current status of NCT04829994 (Post-Market Clinical Follow-Up onTVT EXACT® Continence System) is: ACTIVE_NOT_RECRUITING.

When did Post-Market Clinical Follow-Up onTVT EXACT® Continence System start?

Post-Market Clinical Follow-Up onTVT EXACT® Continence System started on 2021-07-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.